Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Metabolic reprogramming in liver fibrosis
Paul Horn, Frank Tacke
Cell Metabolism (2024) Vol. 36, Iss. 7, pp. 1439-1455
Open Access | Times Cited: 43

Showing 1-25 of 43 citing articles:

Metabolism of hepatic stellate cells in chronic liver diseases: emerging molecular and therapeutic interventions
Mengyao Yan, Cui Yi-min, Qian Xiang
Theranostics (2025) Vol. 15, Iss. 5, pp. 1715-1740
Open Access
Association between overt hepatic encephalopathy and liver pathology after transjugular intrahepatic portosystemic shunt creation in cirrhotic patients
Chaoyang Wang, Yan Gu, Guofeng Zhou, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Adverse impact of metabolic dysfunction on fibrosis regression following direct-acting antiviral therapy: A multicenter study for chronic hepatitis C
Tom Ryu, Young Woon Chang, Soung Won Jeong, et al.
Clinical and Molecular Hepatology (2025)
Open Access
Exploration of Novel Metabolic Mechanisms Underlying Primary Biliary Cholangitis Using Hepatic Metabolomics, Lipidomics, and Proteomics Analysis
Jie Bao, Xuan Zhang, Mao Ye, et al.
Journal of Proteome Research (2025) Vol. 24, Iss. 2, pp. 562-578
Closed Access
Functional mechanisms and potential therapeutic strategies for lactylation in liver disease
Rong Xu, Yitong Hao, Yahui Liu, et al.
Life Sciences (2025) Vol. 363, pp. 123395-123395
Open Access
In Vivo and In Vitro Models of Hepatic Fibrosis for Pharmacodynamic Evaluation and Pathology Exploration
Yanting Hu, Zhongrui Zhang, Akida Adiham, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 2, pp. 696-696
Open Access
Macronutrient modulation in metabolic dysfunction-associated steatotic liver disease – the molecular role of fatty acids versus sugars in human metabolism and disease progression
Sinéad M. Mullin, A. K. Kelly, Méabh B. Ní Chathail, et al.
Advances in Nutrition (2025), pp. 100375-100375
Open Access
Effects of Selected Food Additives on the Gut Microbiome and Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
Sara Jarmakiewicz-Czaja, Aneta Sokal, Rafał Filip
Medicina (2025) Vol. 61, Iss. 2, pp. 192-192
Open Access
Modulation of γδ T cells by USF3: Implications for liver fibrosis and immune regulation
Xianghong Wang, Rong Lin, Dehai Li, et al.
International Immunopharmacology (2025) Vol. 148, pp. 114100-114100
Closed Access
Bile acids and their receptors in hepatic immunity
Stefano Fiorucci, Silvia Marchianò, Eleonora Distrutti, et al.
Liver Research (2025)
Open Access
Preclinical insights into the potential of itaconate and its derivatives for liver disease therapy
Xiaodong Wu, Yanhong Song, Zhengwei Yuan, et al.
Metabolism (2025), pp. 156152-156152
Closed Access
Machine learning-based plasma metabolomics for improved cirrhosis risk stratification
Jingru Song, Z. Gao, Ling‐Ping Lai, et al.
BMC Gastroenterology (2025) Vol. 25, Iss. 1
Open Access
The impact of sleeve gastrectomy on MASH development by regulating the composition of gut microbiota and metabolic homeostasis
Lingxi Ye, Zhenyu Yao, Qiuhui Xuan, et al.
Biochemical and Biophysical Research Communications (2025) Vol. 752, pp. 151466-151466
Closed Access
Molecular mechanisms in liver repair and regeneration: from physiology to therapeutics
Xiao Ma, Tengda Huang, Xi Chen, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access
Clinical Outcomes in Biopsy-Confirmed Steatotic Liver Disease: A Multicenter Prospective Cohort Study
Gi‐Ae Kim, Heejoon Jang, Moon Young Kim, et al.
(2025)
Closed Access
The burden of cancer in metabolic dysfunction-associated steatotic liver disease
Bianca Florentina Pîrvu, Diana Clenciu, Luiza Andreea Beldie, et al.
Romanian Journal of Morphology and Embryology (2025) Vol. 65, Iss. 4, pp. 627-635
Open Access
Cxcl12+ Kupffer Cells Recruit Treg to Regulate Immune Rejection after Liver Transplantation Through the Cxcl12-Cxcr4 Axis
Yurong Luo, Xinqiang Li, Hailun Cai, et al.
(2025)
Closed Access
Synbiotic combination of fructooligosaccharides and probiotics ameliorates the metabolic dysfunction-associated steatotic liver disease
Sang Yoon Lee, Su-Been Lee, Goo-Hyun Kwon, et al.
The Journal of Microbiology (2025) Vol. 63, Iss. 2, pp. e2411002-e2411002
Closed Access
The Novel Long-Acting Peptide S6-FA Attenuates Liver Fibrosis In Vitro and In Vivo
Mingmin Li, Liang Qi, Jin Huang, et al.
ACS Omega (2025)
Open Access
Histidine metabolism drives liver cancer progression via immune microenvironment modulation through metabolic reprogramming
Pengcheng Liu, Fuxin Huang, Peixu Lin, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access
Suppression of Liver Fibrogenesis with Photothermal Sorafenib Nanovesicles via Selectively Inhibiting Glycolysis and Amplification of Active HSCs
Xianjing Xiang, Yaru Shao, Xiang Li, et al.
Molecular Pharmaceutics (2025)
Closed Access
Energy metabolism: an emerging therapeutic frontier in liver fibrosis
Iram Irshad, Saleh A. Alqahtani, Kenichi Ikejima, et al.
Annals of Hepatology (2025), pp. 101896-101896
Open Access
SLC7A5/E2F1/PTBP1/PKM2 axis mediates progression and therapy effect of triple-negative breast cancer through the crosstalk of amino acid metabolism and glycolysis pathway
Chengfei Jiang, Ying-Chen Qian, Xiaoming Bai, et al.
Cancer Letters (2025), pp. 217612-217612
Open Access
Pharmacotherapeutic options for metabolic dysfunction-associated steatotic liver disease: where are we today?
Tobias Puengel, Frank Tacke
Expert Opinion on Pharmacotherapy (2024) Vol. 25, Iss. 9, pp. 1249-1263
Open Access | Times Cited: 3
BRD4: an effective target for organ fibrosis
Qun Wei, Cailing Gan, Meng Sun, et al.
Biomarker Research (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top